Assistant Professor, Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School
Endocrinology
Dr. Howard A. Wolpert, MD
|
|
Give Review
Howard A. Wolpert, MD works in the field of Endocrinology. He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Diabetes Recognition Program". Howard Wolpert is a published physician as well. He has 35 publications published. The latest was: Social relationships among young adults with insulin-dependent diabetes mellitus: ten-year follow-up of an onset cohort. He accepts all Medicare patients.
Publications
- Development of the Likelihood of Low Glucose (LLG) Algorithm for Evaluating Risk of Hypoglycemia: A New Approach for Using Continuous Glucose Data to Guide Therapeutic...
- Patient-Provider Relationships Across the Transition From Pediatric to Adult Diabetes Care: A Qualitative Study.
- Dietary Fat Acutely Increases Glucose Concentrations and Insulin Requirements in Patients With Type 1 Diabetes: Implications for carbohydrate-based bolus dose calculat...
- Health Care Transition in Patients With Type 1 Diabetes: Young adult experiences and relationship to glycemic control.
- Myocardial infarction triggers chronic cardiac autoimmunity in type 1 Diabetes.
- Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline.
- Persistence of individual variations in glycated hemoglobin: analysis of data from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized T...
- Factors predictive of severe hypoglycemia in type 1 Diabetes: analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control ...
- Psychosocial factors associated With use of continuous glucose monitoring.
- Continuous glucose monitoring--coming of age.
- Insulin pump use in adults with type 1 Diabetes--practical issues.
- Sustained benefit of continuous glucose monitoring on A1C, glucose profiles, and hypoglycemia in adults with type 1 Diabetes.
- Factors predictive of use and of benefit from continuous glucose monitoring in type 1 Diabetes.
- The effect of continuous glucose monitoring in well-controlled type 1 Diabetes.
- Continuous glucose monitoring and intensive treatment of type 1 Diabetes.
- Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study.
- Clinical application of emerging sensor technologies in Diabetes management: consensus guidelines for continuous glucose monitoring (CGM).
- Establishing a continuous glucose monitoring program.
- The nuts and bolts of achieving end points With real-time continuous glucose monitoring.
- Transitioning from pediatric to adult care: a new approach to the post-adolescent young person with type 1 Diabetes.
- Perceptions of psychosocial factors and the insulin pump.
- Use of continuous glucose monitoring in the detection and prevention of Hypoglycemia.
- Hands-on demonstration and discussion of new pump software/hardware.
- To pump or not to pump.
- A developmental perspective on the challenges of Diabetes education and care during the young adult period.
- A clinician's perspective on some of the challenges in "closing the loop".
- Metabolic decompensation in pump users due to lispro insulin precipitation.
- Management of Diabetes: are doctors framing the benefits from the wrong perspective?
- Young adults with Diabetes: need for a new treatment paradigm.
- Metabolic control matters: Why is the message lost in the translation? The need for realistic goal-setting in Diabetes care.
- Social relationships among young adults with insulin-dependent Diabetes mellitus: ten-year follow-up of an onset cohort.
- Retinal blood flow changes in patients with insulin-dependent Diabetes mellitus and no diabetic retinopathy.
- Insulin modulates circulating endothelin-1 levels in humans.
- Disparate effects of weight loss on insulin sensitivity and erythrocyte sodium-lithium countertransport activity.
Schools
University Of The Witwatersrand Faculty Of Health Sciences
Deaconess Hospital Boston
Brigham and Women39s Hospital Boston
Procedures Preformed
- Continuous Glucose Monitoring
Conditions Treated
- Abnormal Thyroid
- Acromegaly and Gigantism
- Adrenal Insufficiency
- Calcium Metabolism Disorders
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Diabetes Recognition Program
Education
-
Beth Israel Deaconess Medical Center -
University of the Witwatersrand
Hospital
-
Beth Israel Deaconess Medical Center
Drug Facts
| NPI NUMBER | 1639234586 | |
| NPPES Provider LastName | WOLPERT | |
| NPPES Provider FirstName | HOWARD | |
| NPPES Provider ZIPCode | 02215 | |
| NPPES Provider State | MA | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 1344.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1639234586 |
| Last Name Of The Provider | WOLPERT |
| First Name Of The Provider | HOWARD |
| View All |
Similar Doctors
|
|
Dr. Marc N. Wein, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph A. Majzoub, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ravikumar Balasubramanian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Camille E. Powe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Evan D. Rosen, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Florencia Halperin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joshua D. Safer, MD
This Doctor is OpenDoctor Recommended.
|